Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Business Times.
Press releases published on July 7, 2025
Bluewave Nexor: This Bluewave Nexor App Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval
GlobeNewswire
·
July 7, 2025
New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- As digital transformation continues to redefine global markets, Bluewave Nexor has emerged as one of the most talked-about innovations in AI-driven trading. At a time when market unpredictability and …
BTC Miner Announces Million-Dollar Cloud Mining Opportunity After Bitcoin’s Surge
GlobeNewswire
·
July 7, 2025
New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- You may have missed the Bitcoin surge, but the opportunity isn’t over. BTC Miner offers you a low-barrier, high-reward investment opportunity where you can easily participate in Bitcoin, Ethereum, and …
Redevances OR annonce les livraisons préliminaires d’onces d’équivalent d’or pour le deuxième trimestre de 2025 et des produits trimestriels et une marge monétaire records
GlobeNewswire
·
July 7, 2025
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Redevances OR Inc. (la « Société » ou « Redevances OR ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses produits et sa marge monétaire préliminaires pour le deuxième trimestre …
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
GlobeNewswire
·
July 7, 2025
MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX …
IREN June 2025 Monthly Update
GlobeNewswire
·
July 7, 2025
SYDNEY, July 07, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for June 2025. June Highlights Record monthly revenue and hardware profit3 50 EH/s mid-year …
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
GlobeNewswire
·
July 7, 2025
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new …
The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region
GlobeNewswire
·
July 7, 2025
- Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics - - Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in Royalties and Franchise Fees over the 12 Months Ended March 31, 2025 - SCOTTSDALE …
New Business Book Unveils 17 Proven Rules to Save, Sustain, and Scale Struggling Companies
GlobeNewswire
·
July 7, 2025
CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) -- Veteran business leader and turnaround expert C. Joseph Incrocci announces the release of his newest book, 17 Powerful Rules That Will Save, Sustain, and Scale Your Business, now available on Amazon, Kindle, and …
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
GlobeNewswire
·
July 7, 2025
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development. Mr. Ghias joins BioCryst from …
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema
GlobeNewswire
·
July 7, 2025
Ingelheim, Germany, July 7, 2025 – Boehringer Ingelheim today announces the start of the THULITE Phase II clinical study (NCT06962839). It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision …
OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025
GlobeNewswire
·
July 7, 2025
Oxford, United Kingdom – 7th July 2025 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces that …
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
GlobeNewswire
·
July 7, 2025
WARREN, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
Flagship Communities Real Estate Investment Trust to Host Conference Call for Second Quarter 2025 Results
GlobeNewswire
·
July 7, 2025
Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced that …
OTC Markets Group Welcomes Vroom, Inc. to OTCQX
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vroom, Inc. (“Vroom”) (OTCQX: VRMWW), a leading automotive finance company …
Shoals Technologies Group, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
July 7, 2025
PORTLAND, Tenn., July 07, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its second quarter 2025 results before market open on Tuesday, August 5, 2025, to be followed by …
Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
GlobeNewswire
·
July 7, 2025
LOS ALTOS, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh …
La Caisse and Fondaction invest $250 million by way of a subordinated loan to Boralex
GlobeNewswire
·
July 7, 2025
MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (TSX: BLX) (“Boralex” or the “Company”) announces the closing of an additional corporate financing of $250 million by way of an unsecured subordinated loan with a term of 8 years. The investment is …
La Caisse et Fondaction investissent 250 M$ sous forme de dette subordonnée dans Boralex
GlobeNewswire
·
July 7, 2025
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce la clôture d’un financement corporatif additionnel de 250 M$ sous forme de dette subordonnée non garantie d’une échéance de huit ans. L’ …
Inventus Reports 4.10 gpt Gold and 1.78 Metre Average in 30 Drill Holes Within 6 Metres of Surface at the 10,000-Tonne Trench 1 Bulk Sample Site
GlobeNewswire
·
July 7, 2025
TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce final assays from grade-control drilling of the 10,000-tonne Trench 1 Bulk Sample Site on its 100%-owned Pardo Gold Project, …
Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West
GlobeNewswire
·
July 7, 2025
MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2025 program at Boumadine in the Kingdom of Morocco. Today's …